Epstein-barr Virus Associated Lymphoma
📧 Sign up to get email alerts when something new happens for Epstein-barr Virus Associated Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Donor-Derived EBV-Specific T Cells for Life Threatening EBV-lymphoma (OLIP-EBV-TCL-01-HMR01) [NA]
This clinical trial update notes the completion of a study evaluating donor-derived EBV-specific T cells for Epstein-Barr virus-associated l…
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: Dose Escalation & Expansion Study of Oral VRx-3996 & Valganciclovir in Subjects With EBV+ Lymphoid Malignancies [Phase 1, Phase 2]
Phase 1/2 dose-escalation and expansion study of VRx-3996 with valganciclovir in Epstein-Barr virus-associated lymphoma and other EBV-relate…
-
CLINICAL_TRIALS trial_result · 2013-11-15Clinical Trial Update: Cell Bank of Epstein Barr Virus Specific Cytotoxic T Lymphocytes [Phase 1]
Phase 1 clinical trial evaluating a cell bank of Epstein-Barr virus-specific cytotoxic T lymphocytes for Epstein-Barr virus-associated lymph…